Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Leads $8M Financing Round in GenoLogics

Premium

Laboratory information management system software company GenoLogics said last week that it has closed an $8 million funding round led by Illumina, a new investor in the company.

The financing will be used to develop products for clinical applications and new desktop sequencing systems, and also to expand sales and marketing functions. As part of the deal, Illumina's senior vice president and chief commercial officer, Tristan Orpin, will join GenoLogics' board of directors.

The GenoLogics investment "will benefit our mutual sequencing customers," Orpin said in a statement.

The investment builds on a previous agreement the companies struck up earlier this year to co-sell GenoLogics' LIMS (IS 2/8/2011). In September, GenoLogics released a preconfigured package for Illumina sequencing.

According to GenoLogics CEO Michael Ball, the investment will help customers "overcome some of the most challenging barriers to next-generation sequencing adoption, namely data management."

Additional details of the financing round were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.